¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"D47"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
D47.1
Chronic myeloproliferative disease
¸¸¼º °ñ¼öÁõ½Ä¼º Áúȯ
D47.3
Essential(haemorrhagic) thrombocythaemia
º»Å¼º(ÃâÇ÷¼º) Ç÷¼ÒÆÇ Áõ°¡Áõ
D47.0
Histiocytic and mast cell tumours of uncertain and unknown behaviours
Çൿ¾ç½Ä ºÒ¸í ¹× ¹Ì»óÀÇ Á¶Á÷±¸ ¹× ºñ¸¸¼¼Æ÷ Á¾¾ç
D47.2
Monoclonal gammopathy
´ÜŬ·Ð¼º °¨¸¶º´Áõ
D47.9
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
¸²ÇÁ, Á¶Ç÷ ¹× °ü·Ã Á¶Á÷ÀÇ Çൿ¾ç½Ä ºÒ¸í ¶Ç´Â ¹Ì»óÀÇ »ó¼¼ºÒ¸íÀÇ ½Å»ý¹°
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½